Pierrel SpA

Pierrel S.p.A. is a full service global provider to the pharmaceutical, bio-pharmaceutical and life science industries, specializing in the discovery of MPCs ("Medicinal Product Candidates") and in the repositioning of existing drugs into new therapeutical indications and in clinical research (TCRDO Division), in pharmaceutical manufacturing (Contr... act Manufacturing Division), and in the development, registration and licensing of new drugs and medical devices (Pharma Division). Pierrel Group - listed on the Italian Stock Exchange (MTA) - has more than 60 years of experience in pharmaceutical industry and is one of the leading European producers of local and dental anesthetics. Corporate Office and our production plant are located in Capua (CE), near Naples. The production site of the Contract Manufacturing Division is approved by EMA ("European Medicines Agency"), for aseptic production of dental anesthetics since 1948, and FDA ("Food and Drug Administration") since October 2009, for production of "Sterile Filled Small Volumes Parenteral Drugs". Through THERAMetrics - our full-service TCRDO (Technology-driven Contract Research & Development Organization including cGMP IMP Services) - we provide regulatory consulting, technological services and solutions to innovative biopharmaceutical companies throughout the entire drug discovery & development cycle - from Preclinical to Market Access. Our major operating locations are in Thalwil Switzerland, in Essen Germany, in Timisoara Romania, in Sesto San Giovanni Italy and Wayne Philadelphia, USA. Our worldwide staff thus enables a high level of local expertise to be applied to international clinical trials. Our subsidiary Pierrel Pharma S.r.l. registered and distributes the dental anesthetic Orabloc® in Canada, USA, Russia and Europe.Read More